US2017258960A1PendingUtilityA1

Inorganically surface-modified polymers and methods for making and using them

Assignee: UNIV CALIFORNIAPriority: Jul 6, 2010Filed: Jan 29, 2017Published: Sep 14, 2017
Est. expiryJul 6, 2030(~3.9 yrs left)· nominal 20-yr term from priority
A61P 31/00B32B 27/32Y10T428/24802B32B 2255/205B32B 9/005B32B 2255/10A61K 35/28A61K 38/00C08L 23/02B32B 2264/107A61L 27/54C08L 23/06C08G 2650/40A61K 31/7088A61L 2400/18A61K 35/545B32B 2270/00C08L 71/00B32B 2535/00B82Y 5/00B32B 2264/102B32B 15/18A61L 27/16B32B 2264/02A61L 27/3804B32B 15/08A61P 19/08B32B 2264/105B32B 27/288B32B 2307/732A61K 35/32
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

In alternative embodiments, the invention provides articles of manufacture comprising biocompatible nanostructures comprising PolyEther EtherKetone (PEEK) surface-modified (surface-nanopatterned) to exhibit nanostructured surfaces that promote osseointegration and bone-bonding for, e.g., joint (e.g., knee, hip and shoulder) replacements, bone or tooth reconstruction and/or implants, including their use in making and using artificial tissues and organs, and related, diagnostic, screening, research and development and therapeutic uses, e.g., as primary or ancillary drug delivery devices. In alternative embodiments, the invention provides biocompatible nanostructures that promote osseointegration and bone-bonding for enhanced cell and bone growth and e.g., for in vitro and in vivo testing, restorative and reconstruction procedures, implants and therapeutics.

Claims

exact text as granted — not AI-modified
1 . A product of manufacture comprising:
 (a) a thermoplastic polymer; and   (b) a biocompatible surface layer deposited on at least a portion of the thermoplastic polymer, wherein the biocompatible surface layer comprises a plurality of nanotubular structures that each have a diameter of approximately 5 to 1000 nanometers (nm) and a height of approximately 30 nm to 3 micrometer, or a height of approximately 30 nm to 500 nm.   
     
     
         2 . The product of manufacture of  claim 1 , wherein at least approximately 50% of the biocompatible surface layer is covered by the plurality of nanotubular structures, or substantially all of the biocompatible surface layer is covered by the plurality of nanotubular structures. 
     
     
         3 . The product of manufacture of  claim 1 , wherein any of the biocompatible surface layer and the plurality of nanotubular structures comprise a material selected from the group consisting of:
 (i) a Ti, a Zr, a Hf, a Nb, a Ta, a Mo and a W metal;   (ii) an oxide of a Ti, a Zr, a Hf, a Nb, a Ta, a Mo and a W metal;   (iii) an alloy of a Ti, a Zr, a Hf, a Nb, a Ta, a Mo and a W metal;   (iv) a Si, a Si oxide, an Al, an Al oxide, a carbon, a diamond, a noble metal, an Au, an Ag, a Pt, an Ag oxide, and a Pt alloy,   (v) a plastic material,   (vi) a composite metal,   (vii) a ceramic,   (vii) a polymer, and   (viii) a combination thereof.   
     
     
         4 . The product of manufacture of  claim 1 , further comprising any of at least one of a bone cell, a liver cell, a kidney cell, a blood vessel cell, a skin cell, a periodontal cell, a periodontal tissue cell, a stem cell, an organ cell, a fully differentiated osteoblast cell, a partially differentiated osteoblast cell, a mesenchymal stem cell (MSC), a human mesenchymal stem cell (hMSC), an embryonic stem cell, an adult stem cell, endothelial cells, adipocytes, fibroblastic cells, Kupffer cells, odontoblasts, dentinoblasts, cementoblasts, enameloblasts, odontogenic ectomesenchymal tissue, osteoblasts, osteoclasts, fibroblasts, a cell involved in odontogenesis or bone formation, a human cell, an animal cell, and a combination thereof. 
     
     
         5 . The product of manufacture of  claim 1 , wherein the biocompatible surface layer includes any of a hydroxyapatite, a bio-degradable polymer, a bio-compatible cement, a bio-inert bone cement, a biological agent, a therapeutic composition, an osteogenic inducing agent, a growth factor, a collagen, a nucleic acid, an antibiotic, a hormone, a drug, a magnetic particle, a metallic particle, a ceramic particle, a polymer particle, a drug delivery particle, and a combination thereof. 
     
     
         6 . The product of manufacture of  claim 1 , wherein the plurality of nanotubular structures:
 (a) are in the form of any of nanowires, nano-lines, nano-grooves, nanotubes, nanopores, and a combination thereof; or   (b) are made by any of anodization, patterned chemical etching, and a combination thereof.   
     
     
         7 . The product of manufacture of  claim 1 , wherein the plurality of nanotubular structures and spacing between adjacent nanotubular structures act as a nanodepot that stores any of a metal, an oxide, a hydroxyapatite, a bio-degradable polymer, a bio-compatible, a bio-inert bone cement, a cell, a stem cell, an osteogenic inducing agent, a biological agent, a therapeutic composition, a growth factor, a collagen, a nucleic acid, an antibiotic, a hormone, a drug, a magnetic particle, a metallic particle, a ceramic particle, a polymer particle, a drug delivery particle, and a combination thereof. 
     
     
         8 . A device comprising a product of manufacture of  claim 1 , and optionally the device is a delivery device. 
     
     
         9 . An implant comprising a product of manufacture of  claim 1 ,
 and optionally the implant is any of a medical implant, an orthopedic implant, a joint implant, a joint replacement, a dental implant, a tooth implant, a knee implant, a hip implant, a shoulder implant, a joint implant, a joint replacement, a dental replacement, a tooth replacement, a knee replacement, a hip replacement, and a shoulder replacement.   
     
     
         10 . A product of manufacture of  claim 1 , fabricated for any of in vivo hard tissue applications, in vivo soft tissue applications, and in vivo hard tissue and soft tissue applications. 
     
     
         11 . The product of manufacture of  claim 10 , wherein the in vivo soft tissue applications include any of: use with a catheter, use with an implantable device that promotes cell growth, and, use with a biosensor that reduces a fibrotic capsule which blocks any of an electrical and a chemical signal. 
     
     
         12 . The product of manufacture of  claim 10 , wherein the in vivo hard tissue applications include any of:
 an orthopedic implant,   an orthopedic replacement,   a joint implant,   a joint replacement,   a hip stem,   a knee implant,   a shoulder replacement,   a dental implant,   a craniofacial implant;   a spine application,   a cervical instrumentation,   a thoracic instrumentation,   a lumbar spinal instrumentation,   an interbody vertebral cage,   a pedicle screw,   a bone substitute material,   a bone void filler,   a bone graft material, and   a combination thereof.   
     
     
         13 . The product of manufacture of  claim 10 , wherein the in vivo hard tissue and soft tissue applications include any of:
 a trauma application,   a fixation device,   an internal fixation device,   an external fixation device,   a fixation device,   an internal fixation device,   an external fixation device, and   a rod.   
     
     
         14 . A product of manufacture of  claim 1 , fabricated for in vitro applications. 
     
     
         15 . The product of manufacture of  claim 1 , wherein the thermoplastic polymer:
 (a) is any of a PolyEther EtherKetone (PEEK), a PolyEtherKetoneKetone (PEKK), a PolyEther EtherKetone (PEEK), an ultra-high-molecular-weight polyethylene (UHMWPE), a combination thereof, and an equivalent material thereof; or   (b) comprises a nano-patterned PolyEther EtherKetone (PEEK) and the biocompatible surface layer comprises a layer of titanium (Ti) sputtered on a surface of the thermoplastic polymer.   
     
     
         16 . The product of manufacture of  claim 1 , wherein the plurality of nanotubular structures:
 (a) comprise any of a metal, a metal alloy, a stainless steel, and a ceramic, and optionally the metal and the metal alloy comprise any of a Ti metal, a Zr metal, a Hf metal, a Nb metal, a Ta metal, a Mo metal, a W metal, a Ti alloy, a Zr alloy, a Hf alloy, a Nb alloy, a Ta alloy, a Mo alloy, a W alloy, a Ti oxide, a Zr oxide, a Hf oxide, a Nb oxide, a Ta oxide, a Mo oxide, a W oxide, and a nitride,   (b) are any of straight, curved, and bent, or are arranged as any of an array and a three-dimensional network scaffold; or   (c) each have a diameter of approximately 60 to 150 nm; or the plurality of nanotubular structures are approximately 100 nanometers (nm) in diameter; or the plurality of nanotubular structures are approximately 80 to 120 nanometers (nm) in diameter; or the plurality of nanotubular structures each has a diameter of approximately 8 nanometers (nm).   
     
     
         17 - 19 . (canceled) 
     
     
         20 . The product of manufacture of  claim 1 , wherein:
 (a) there is a spacing between the plurality of nanotubular structures of approximately 70 to 200 nanometers (nm); the spacing between the plurality of nanotubular structures is approximately 60 to 150 nanometers (nm); the spacing between the plurality of nanotubular structures is approximately 80 to 120 nanometers (nm);   (b) the plurality of nanotubular structures each have a diameter of approximately 5 to 15 nm and approximately a 0.1 to 3 micrometer height;   (c) the plurality of nanotubular structures each have height of approximately 0.1 to 3 micrometer; or   (d) the plurality of nanotubular structures each have height of approximately 30 nm to 500 nm.   
     
     
         21 - 22 . (canceled) 
     
     
         23 . The product of manufacture of  claim 1 , wherein:
 (a) the thermoplastic polymer comprises a plurality of nano-imprints, wherein at least a portion of the plurality of nano-imprints are formed using a pair of nano-imprint stamps, wherein the first of the pair of nano-imprint stamps faces the inner wall and the second of the pair of nano-imprint stamps faces the outer wall,   wherein optionally at least a portion of the plurality of nano-imprints each have a re-entrant pore geometry, optionally formed using a process comprising a warm compression of the thermoplastic polymer,   and optionally the re-entrant pore geometry comprises an entrance diameter, or an average diameter if the nano-imprint is not circular, which is smaller than the maximum average diameter within the nano-imprint,   and optionally the warm compression comprises applying a warm compressive plastic deforming force in a vertical direction to partially squash at least a portion of the thermoplastic polymer to the re-entrant pore geometry;   and optionally the re-entrant pore geometry comprises a nano-pore, wherein a ratio of a maximum inner-pore diameter to the entrance diameter is at least 1.05.   
     
     
         24 - 30 . (canceled)

Join the waitlist — get patent alerts

Track US2017258960A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.